The "PROgrammable, cancer TargEted and Cancer responsive therapeutics and Theranostics" (PROTECT) project is aiming to provide insight on the chemical space requirements to develop selective modulators for the undruggable oncogenic Intrinsically Disordered Proteins (IDPs) and to generate programmable, cancer selective and cancer responsive drug delivery vehicles for their selective transport in cancer cells.
It is a cooperation among the the Laboratory of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina (Greece), the Magnetic Resonance Center (CERM), of University of Florence (Italy), the Faculty of Medicine, Department of Medicine, Imperial College, London (UK) and the Stanford University, Department of Chemistry, Stanford (USA), hosted by the University of Ioannina.
The project is funded by the Hellenic Foundation for Research & Innovation (H.F.R.I. - ΕΛ.ΙΔ.Ε.Κ.).
